While U.S. investors are benefiting from the crypto ETF surge, retail investors outside the U.S. face barriers in accessing ...

Listed companies such as Voltas, Blue Star, Amber, and Epack have submitted applications in this phase, with a proposed ...

On Monday, Oppenheimer reiterated its Outperform rating and $42.00 price target for Pharvaris B.V. (NASDAQ: PHVS), a biopharmaceutical company. The reaffirmation follows a recent discussion with ...

DALLAS - Lantern Pharma Inc. (NASDAQ: LTRN) has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation ... companies investing heavily in R&D.

On Monday, Oppenheimer reiterated its Outperform rating and $42.00 price target for Pharvaris B.V. (NASDAQ: PHVS), a biopharmaceutical company. The reaffirmation follows a recent discussion with the ...

Wales-based biotech company Antiverse has raised $4.6 million in seed funding. AI and biotech startups are continuing to ...

Exchange-traded funds (ETFs) have revolutionized investing ... about 93% of the total market cap of all listed stocks in the U.S. equity market. The fund aims to closely track the index's return ...

BOSTON - Elevation Oncology, Inc. (NASDAQ:ELEV) has received Fast Track designation from the U.S. Food and Drug ... Visit InvestingPro for an in-depth analysis and more expert tips to inform your ...

The company's regular quarterly payout of $0.15 per share plus February's special dividend of $0.18 per share puts it on track to dish out ... half the earnings of $1.93 per share that analysts ...

A specialist in macro investing, 93 East Capital fits the bill ... and provide monthly updates on our latest thinking on markets and the economy With a proven track record of delivering uncorrelated ...